Todd Gross, PhD
Todd Gross, PhD, has more than 25 years of experience in biostatistics and clinical development in the pharmaceutical and medical device industries. Todd uses his expertise in analysis and interpretation of clinical data, clinical study design, endpoint selection, and patient-reported outcomes (PRO) development and validation, to help clients prepare for FDA interactions and advisory committee meetings. Todd was head of biostatistics at Allergan Medical, Kythera, Medtronic Diabetes, and Boston Scientific Neuromodulation. He achieved regulatory approval and market adoption of more than a dozen drug and device products, and was involved in numerous successful advisory committee meetings. Todd has performed research in diabetes, obesity, dermatology, pain management, and audiology, as well as academic research in cognitive psychology and device usability. He has authored two dozen scientific publications on topics from diabetes to medical devices. Todd has a PhD from UCLA, and is currently an Associate Professor of Statistics at the University of California, Santa Barbara.